Kazia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.1%.

Top 19 shareholders own 12.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.33%	Alumni Capital Management	158,793	US$878.1k	-51.9%	no data
4.58%	MAI Capital Management, LLC	136,389	US$754.2k	0%	0.01%
0.84%	UBS Asset Management AG	24,945	US$137.9k	969%	no data
0.74%	Morgan Stanley, Investment Banking and Brokerage Investments	22,026	US$121.8k	9.54%	no data
0.2%	Citadel Advisors LLC	6,047	US$33.4k	1,230%	no data
0.15%	Jane Street Group, LLC, Asset Management Arm	4,611	US$25.5k	0%	no data
0.15%	United Bank (Fairfax, VA), Asset Management Arm	4,400	US$24.3k	0%	no data
0.13%	JPMorgan Chase & Co, Brokerage and Securities Investments	3,782	US$20.9k	378,000%	no data
0.1%	Commonwealth Equity Services, LLC	3,050	US$16.9k	0%	no data
0.093%	Rhumbline Advisers Ltd Partnership	2,780	US$15.4k	57.9%	no data
0.079%	XTX Holdings Limited, Asset Management Arm	2,339	US$12.9k	0%	no data
0.051%	CapFinancial Partners, LLC, Asset Management Arm	1,526	US$8.4k	0%	no data
0.05%	Geode Capital Management, LLC	1,478	US$8.2k	200%	no data
0.034%	Traynor Capital Management, Inc.	1,000	US$5.5k	0%	no data
0.0017%	Osaic Wealth, Inc. , Asset Management Arm	50	US$276.8	0%	no data
0.0017%	Wells Fargo & Company, Securities and Brokerage Investments	50	US$276.8	0%	no data
0.0017%	Simplex Trading, LLC, Asset Management Arm	50	US$276.8	0%	no data
0.00027%	Allworth Financial, L.P.	8	US$44.5	0%	no data
0.00003%	AdvisorNet Wealth Management	1	US$4.9	0%	no data